Medical Weight-Loss

Service Description

Reach your health goals with Medical Weight-Loss Assistance. Our licensed medical professionals are dedicated to helping you achieve a healthy weight through lifestyle guidance and medical weight-loss assistance. We offer weight loss with GLP-1 peptides. These medications are proven to help you lose more weight when added to diet and exercise. Schedule your free consultation today and start your journey towards a healthier and happier you. In clinic and virtual visits available. $350/Month GLP-1 GLP-1 agonists (Glucagon-like peptide-1) are a type of diabetes medication that is used to help people manage their diabetes and promote weight loss. GLP-1 agonists mimic the hormone GLP-1, which is naturally produced in the body. GLP-1 is an incretin hormone that helps stimulate the release of insulin in response to the ingestion of food. GLP-1 agonists can reduce appetite, slow digestion, and increase the sensation of feeling full. Injectable GLP-1 is a once weekly medication used in conjunction with diet and exercise to promote weight loss. Starting at $450/Month GLP-1/GIP GLP-1 (Glucagon-like peptide-1) and GIP (Gastric inhibitory peptide) agonists are also a type of diabetes medication. GLP-1 and GIP are both incretin hormones, that help stimulate the release of insulin in response to the ingestion of food. These dual GIP-GLP1 receptor agonists work in the same way by reducing appetite, slowing digestion, and increasing sensation of feeling full. Injectable GIP/GLP-1 agonist is a once weekly medication used in conjunction with diet and exercise to promote weight loss. Who should not take these medications? • Persons who have a history of pancreatitis • Persons with type 1 diabetes • Persons taking insulin • Persons with retinopathy • Persons with severe gastrointestinal disease or kidney problems • Persons who are allergic to the drug's ingredients • Persons who are pregnant • Persons or any family members who have been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or Medullary thyroid cancer